
We're delighted to have advised DIOSynVax on its $42m deal with @CEPIvaccines. @PatrickFarrant commented: ”We are delighted to have supported @JonathanHeeney and his team on this transformative deal.” Read more here: eu1.hubs.ly/y0tXKk0. @Cambridge_Uni




















